Acadia Pharmaceuticals (ACAD) Current Taxes (2022 - 2024)

Acadia Pharmaceuticals' Current Taxes history runs 3 years deep, the most recent figure standing at $8.5 million for Q2 2024.

• On a quarterly basis, Current Taxes changed N/A year-over-year to $8.5 million in Q2 2024; TTM through Jun 2024 was $8.5 million, a N/A change from a year earlier, with the FY2023 full-year figure at $8.7 million, up 2210.34% from the prior year.
• Current Taxes grew to $8.5 million in Q2 2024 per ACAD's latest filing, from $7.6 million in the prior quarter.
• Across five years, Current Taxes topped out at $8.7 million in Q4 2023 and bottomed at $377000.0 in Q4 2022.
• The 3-year median for Current Taxes is $8.5 million (2023), against an average of $6.7 million.
• Biggest YoY gain for Current Taxes was 2210.34% in 2023; the steepest drop was 2210.34% in 2023.
• Year by year, Current Taxes stood at $377000.0 in 2022, then soared by 2210.34% to $8.7 million in 2023, then dropped by 2.92% to $8.5 million in 2024.
• Per Business Quant, the three latest ACAD Current Taxes figures stand at $8.5 million (Q2 2024), $7.6 million (Q1 2024), and $8.7 million (Q4 2023).